Satyanarayana Rachagani, PhD

Assistant Professor

  • 2324 Citations
  • 24 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Satyanarayana Rachagani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Mucins Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
gemcitabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 2324 Citations
  • 24 h-Index
  • 63 Article
  • 8 Review article
  • 2 Comment/debate
  • 1 Short survey

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Vengoji, R., Macha, M. A., Nimmakayala, R. K., Rachagani, S., Siddiqui, J. A., Mallya, K., Gorantla, S., Jain, M., Palanimuthu Ponnusamy, M., Batra, S. K. & Shonka, N. A., Jun 18 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 266.

Research output: Contribution to journalArticle

Open Access
temozolomide
Glioblastoma
Carcinogenesis
Neoplastic Stem Cells
Epidermal Growth Factor Receptor
Open Access
Blood Vessels
Prostatic Neoplasms
Perfusion
Neoplasms
Bombesin Receptors
3 Citations (Scopus)

Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer

Uz, M., Kalaga, M., Pothuraju, R., Ju, J., Junker, W. M., Batra, S. K., Mallapragada, S. & Rachagani, S., Jan 28 2019, In : Journal of Controlled Release. 294, p. 237-246 10 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Equipment and Supplies
Heterografts
Neoplasms
3 Citations (Scopus)

Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition

Abdalla, M. Y., Ahmad, I. M., Rachagani, S., Banerjee, K., Thompson, C. M., Maurer, H. C., Olive, K. P., Bailey, K. L., Britigan, B. E. & Kumar, S., May 1 2019, In : Translational Research. 207, p. 56-69 14 p.

Research output: Contribution to journalArticle

gemcitabine
Heme Oxygenase-1
Pancreatic Neoplasms
Cells
Adenocarcinoma

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis

Seshacharyulu, P., Rachagani, S., Muniyan, S., Siddiqui, J. A., Cruz, E., Sharma, S., Krishnan, R., Killips, B. J., Sheinin, Y., Lele, S. M., Smith, L. M., Talmon, G. A., Palanimuthu Ponnusamy, M., Datta, K. & Batra, S. K., Jun 27 2019, In : Oncogene. 38, 26, p. 5265-5280 16 p.

Research output: Contribution to journalArticle

Geranyltranstransferase
Monomeric GTP-Binding Proteins
Prostatic Neoplasms
Mevalonic Acid
zoledronic acid